ID CANB1_RAT Reviewed; 170 AA. AC P63100; P06705; P15117; Q08044; DT 01-JAN-1988, integrated into UniProtKB/Swiss-Prot. DT 23-JAN-2007, sequence version 2. DT 02-SEP-2026, entry version 155. DE RecName: Full=Calcineurin subunit B type 1; DE AltName: Full=Protein phosphatase 2B regulatory subunit 1; DE AltName: Full=Protein phosphatase 3 regulatory subunit B alpha isoform 1; GN Name=Ppp3r1; Synonyms=Cna2, Cnb; OS Rattus norvegicus (Rat). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Rattus. OX NCBI_TaxID=10116; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). RC STRAIN=Fischer; RA Perrino B.A., Huang X., Ng L.Y., Soderling T.R.; RT "Regulation of calcineurin phosphatase activity by the B subunit and RT carboxy-terminal inhibitory domains of the A subunit."; RL Submitted (OCT-1992) to the EMBL/GenBank/DDBJ databases. RN [2] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), AND TISSUE SPECIFICITY. RC TISSUE=Brain, and Testis; RX PubMed=8110831; DOI=10.1016/0167-4781(94)90031-0; RA Chang C.-D., Mukai H., Kuno T., Tanaka C.; RT "cDNA cloning of an alternatively spliced isoform of the regulatory subunit RT of Ca2+/calmodulin-dependent protein phosphatase (calcineurin B alpha 2)."; RL Biochim. Biophys. Acta 1217:174-180(1994). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). RC TISSUE=Brain; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [4] RP MYRISTOYLATION AT GLY-2, AND IDENTIFICATION BY MASS SPECTROMETRY. RA Lubec G., Chen W.-Q.; RL Submitted (FEB-2007) to UniProtKB. RN [5] RP X-RAY CRYSTALLOGRAPHY (3.00 ANGSTROMS) OF 2-170 IN COMPLEX WITH CALCIUM, RP AND FUNCTION. RX PubMed=24018048; DOI=10.1016/j.cellsig.2013.08.033; RA Ye Q., Feng Y., Yin Y., Faucher F., Currie M.A., Rahman M.N., Jin J., RA Li S., Wei Q., Jia Z.; RT "Structural basis of calcineurin activation by calmodulin."; RL Cell. Signal. 25:2661-2667(2013). CC -!- FUNCTION: Regulatory subunit of calcineurin, a calcium-dependent, CC calmodulin stimulated protein phosphatase. Confers calcium sensitivity. CC {ECO:0000269|PubMed:24018048}. CC -!- SUBUNIT: Forms a complex composed of a calmodulin-dependent catalytic CC subunit (also known as calcineurin A) and a regulatory Ca(2+)-binding CC subunit (also known as calcineurin B) (PubMed:24018048). There are CC three catalytic subunits, each encoded by a separate gene (PPP3CA, CC PPP3CB, and PPP3CC) and two regulatory subunits which are also encoded CC by separate genes (PPP3R1 and PPP3R2). The regulatory subunit confers CC calcium sensitivity. Interacts with catalytic subunit CC PPP3CA/calcineurin A (PubMed:24018048). Interacts with catalytic CC subunit PPP3CB/calcineurin A (By similarity). Interacts with CIB1 (via CC C-terminal region); the interaction increases upon cardiomyocyte CC hypertrophy. Interacts with RCAN1 (By similarity). Interacts with CC SPATA33 (via PQIIIT motif) (By similarity). CC {ECO:0000250|UniProtKB:P63098, ECO:0000250|UniProtKB:Q63810, CC ECO:0000305|PubMed:24018048}. CC -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol CC {ECO:0000250|UniProtKB:Q63810}. Cell membrane CC {ECO:0000250|UniProtKB:Q63810}. Cell membrane, sarcolemma CC {ECO:0000250|UniProtKB:Q63810}. Cell membrane CC {ECO:0000250|UniProtKB:P63098}; Lipid-anchor CC {ECO:0000250|UniProtKB:P63098}. Note=Translocates from the cytosol to CC the sarcolemma in a CIB1-dependent manner during cardiomyocyte CC hypertrophy. {ECO:0000250|UniProtKB:Q63810}. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=2; CC Name=1; CC IsoId=P63100-1, P06705-1; Sequence=Displayed; CC Name=2; CC IsoId=P63100-2, P06705-2; Sequence=VSP_000729; CC -!- TISSUE SPECIFICITY: Isoform 2 is testis specific. CC {ECO:0000269|PubMed:8110831}. CC -!- MISCELLANEOUS: This protein has four functional calcium-binding sites. CC {ECO:0000269|PubMed:24018048}. CC -!- SIMILARITY: Belongs to the calcineurin regulatory subunit family. CC {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; L03554; AAA40854.1; -; mRNA. DR EMBL; D14568; BAA03422.1; -; mRNA. DR EMBL; D14425; BAA03318.1; -; mRNA. DR EMBL; BC088855; AAH88855.1; -; mRNA. DR PIR; S42716; S42716. DR RefSeq; NP_059005.1; NM_017309.3. [P63100-1] DR RefSeq; XP_006251579.3; XM_006251517.5. [P63100-2] DR PDB; 4IL1; X-ray; 3.00 A; A/B/C/D=2-170. DR AlphaFoldDB; P63100; -. DR SMR; P63100; -. DR BioGRID; 248359; 3. DR CORUM; P63100; -. DR FunCoup; P63100; 4406. DR IntAct; P63100; 3. DR MINT; P63100; -. DR STRING; 10116.ENSRNOP00000058834; -. DR iPTMnet; P63100; -. DR PhosphoSitePlus; P63100; -. DR SwissPalm; P63100; -. DR jPOST; P63100; -. DR PaxDb; 10116-ENSRNOP00000058834; -. DR DNASU; 29748; -. DR Ensembl; ENSRNOT00000031275.8; ENSRNOP00000037143.6; ENSRNOG00000065686.2. [P63100-2] DR Ensembl; ENSRNOT00000158230.1; ENSRNOP00000111194.1; ENSRNOG00000065686.2. [P63100-1] DR Ensembl; ENSRNOT00055013521; ENSRNOP00055010842; ENSRNOG00055008015. [P63100-1] DR Ensembl; ENSRNOT00060026061; ENSRNOP00060020868; ENSRNOG00060015185. [P63100-1] DR Ensembl; ENSRNOT00065008210; ENSRNOP00065005753; ENSRNOG00065005530. [P63100-1] DR GeneID; 29748; -. DR KEGG; rno:29748; -. DR UCSC; RGD:69230; rat. DR AGR; RGD:69230; -. DR CTD; 5534; -. DR RGD; 69230; Ppp3r1. DR eggNOG; KOG0034; Eukaryota. DR GeneTree; ENSGT00940000156530; -. DR HOGENOM; CLU_061288_10_1_1; -. DR InParanoid; P63100; -. DR OrthoDB; 13321at9989; -. DR PhylomeDB; P63100; -. DR Reactome; R-RNO-111447; Activation of BAD and translocation to mitochondria. DR Reactome; R-RNO-2025928; Calcineurin activates NFAT. DR Reactome; R-RNO-2871809; FCERI mediated Ca+2 mobilization. DR Reactome; R-RNO-4086398; Ca2+ pathway. DR Reactome; R-RNO-5607763; CLEC7A (Dectin-1) induces NFAT activation. DR PRO; PR:P63100; -. DR Proteomes; UP000002494; Chromosome 14. DR Bgee; ENSRNOG00000043210; Expressed in Ammon's horn and 19 other cell types or tissues. DR ExpressionAtlas; P63100; baseline. DR GO; GO:0005955; C:calcineurin complex; IBA:GO_Central. DR GO; GO:0005829; C:cytosol; TAS:Reactome. DR GO; GO:0005886; C:plasma membrane; ISS:UniProtKB. DR GO; GO:0042383; C:sarcolemma; IEA:UniProtKB-SubCell. DR GO; GO:0005509; F:calcium ion binding; IEA:InterPro. DR GO; GO:0008597; F:calcium-dependent protein serine/threonine phosphatase regulator activity; IBA:GO_Central. DR GO; GO:0019902; F:phosphatase binding; IBA:GO_Central. DR GO; GO:0033173; P:calcineurin-NFAT signaling cascade; IBA:GO_Central. DR CDD; cd00051; EFh; 1. DR FunFam; 1.10.238.10:FF:000047; Calcineurin subunit B type 1; 1. DR Gene3D; 1.10.238.10; EF-hand; 1. DR InterPro; IPR011992; EF-hand-dom_pair. DR InterPro; IPR018247; EF_Hand_1_Ca_BS. DR InterPro; IPR002048; EF_hand_dom. DR PANTHER; PTHR45942; PROTEIN PHOSPATASE 3 REGULATORY SUBUNIT B ALPHA ISOFORM TYPE 1; 1. DR Pfam; PF13499; EF-hand_7; 2. DR PRINTS; PR01697; PARVALBUMIN. DR SMART; SM00054; EFh; 4. DR SUPFAM; SSF47473; EF-hand; 1. DR PROSITE; PS00018; EF_HAND_1; 4. DR PROSITE; PS50222; EF_HAND_2; 4. DR PDBsum; 4IL1; -. PE 1: Evidence at protein level; KW 3D-structure; Alternative splicing; Calcium; Cell membrane; Cytoplasm; KW Lipoprotein; Membrane; Metal-binding; Myristate; Phosphoprotein; KW Reference proteome; Repeat. FT INIT_MET 1 FT /note="Removed" FT /evidence="ECO:0000269|Ref.4" FT CHAIN 2..170 FT /note="Calcineurin subunit B type 1" FT /id="PRO_0000073486" FT DOMAIN 18..46 FT /note="EF-hand 1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT DOMAIN 50..85 FT /note="EF-hand 2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT DOMAIN 87..122 FT /note="EF-hand 3" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT DOMAIN 128..163 FT /note="EF-hand 4" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT REGION 131..136 FT /note="Calcineurin A binding" FT /evidence="ECO:0000250|UniProtKB:P63098" FT BINDING 31 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448, FT ECO:0000269|PubMed:24018048, ECO:0007744|PDB:4IL1" FT BINDING 33 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448, FT ECO:0000269|PubMed:24018048, ECO:0007744|PDB:4IL1" FT BINDING 35 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448, FT ECO:0000269|PubMed:24018048, ECO:0007744|PDB:4IL1" FT BINDING 37 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448, FT ECO:0000269|PubMed:24018048, ECO:0007744|PDB:4IL1" FT BINDING 42 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448, FT ECO:0000269|PubMed:24018048, ECO:0007744|PDB:4IL1" FT BINDING 63 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448, FT ECO:0000269|PubMed:24018048, ECO:0007744|PDB:4IL1" FT BINDING 65 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448, FT ECO:0000269|PubMed:24018048, ECO:0007744|PDB:4IL1" FT BINDING 67 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448, FT ECO:0000269|PubMed:24018048, ECO:0007744|PDB:4IL1" FT BINDING 69 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448, FT ECO:0000269|PubMed:24018048, ECO:0007744|PDB:4IL1" FT BINDING 74 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448, FT ECO:0000269|PubMed:24018048, ECO:0007744|PDB:4IL1" FT BINDING 100 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="3" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448, FT ECO:0000269|PubMed:24018048, ECO:0007744|PDB:4IL1" FT BINDING 102 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="3" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448, FT ECO:0000269|PubMed:24018048, ECO:0007744|PDB:4IL1" FT BINDING 104 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="3" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448, FT ECO:0000269|PubMed:24018048, ECO:0007744|PDB:4IL1" FT BINDING 106 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="3" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448, FT ECO:0000269|PubMed:24018048, ECO:0007744|PDB:4IL1" FT BINDING 111 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="3" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448, FT ECO:0000269|PubMed:24018048, ECO:0007744|PDB:4IL1" FT BINDING 141 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="4" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448, FT ECO:0000269|PubMed:24018048, ECO:0007744|PDB:4IL1" FT BINDING 143 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="4" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448, FT ECO:0000269|PubMed:24018048, ECO:0007744|PDB:4IL1" FT BINDING 145 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="4" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448, FT ECO:0000269|PubMed:24018048, ECO:0007744|PDB:4IL1" FT BINDING 147 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="4" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448, FT ECO:0000269|PubMed:24018048, ECO:0007744|PDB:4IL1" FT BINDING 152 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="4" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448, FT ECO:0000269|PubMed:24018048, ECO:0007744|PDB:4IL1" FT SITE 118 FT /note="Interaction with PxVP motif in substrates of the FT catalytic subunit" FT /evidence="ECO:0000250|UniProtKB:P63098" FT SITE 122 FT /note="Interaction with PxVP motif in substrates of the FT catalytic subunit" FT /evidence="ECO:0000250|UniProtKB:P63098" FT MOD_RES 106 FT /note="Phosphotyrosine" FT /evidence="ECO:0000250|UniProtKB:Q63810" FT LIPID 2 FT /note="N-myristoyl glycine" FT /evidence="ECO:0000269|Ref.4" FT VAR_SEQ 1..2 FT /note="MG -> MEQGTDLQSQIFFPTEKNFWKKGKDHFRQNKYPFSRELYNLIFADR FT KG (in isoform 2)" FT /evidence="ECO:0000303|PubMed:8110831" FT /id="VSP_000729" FT HELIX 17..30 FT /evidence="ECO:0007829|PDB:4IL1" FT STRAND 35..38 FT /evidence="ECO:0007829|PDB:4IL1" FT HELIX 40..43 FT /evidence="ECO:0007829|PDB:4IL1" FT TURN 47..51 FT /evidence="ECO:0007829|PDB:4IL1" FT HELIX 55..62 FT /evidence="ECO:0007829|PDB:4IL1" FT STRAND 67..71 FT /evidence="ECO:0007829|PDB:4IL1" FT HELIX 72..80 FT /evidence="ECO:0007829|PDB:4IL1" FT HELIX 88..99 FT /evidence="ECO:0007829|PDB:4IL1" FT STRAND 104..107 FT /evidence="ECO:0007829|PDB:4IL1" FT HELIX 109..120 FT /evidence="ECO:0007829|PDB:4IL1" FT HELIX 126..140 FT /evidence="ECO:0007829|PDB:4IL1" FT STRAND 142..148 FT /evidence="ECO:0007829|PDB:4IL1" FT HELIX 150..157 FT /evidence="ECO:0007829|PDB:4IL1" SQ SEQUENCE 170 AA; 19300 MW; C904715DC0386056 CRC64; MGNEASYPLE MCSHFDADEI KRLGKRFKKL DLDNSGSLSV EEFMSLPELQ QNPLVQRVID IFDTDGNGEV DFKEFIEGVS QFSVKGDKEQ KLRFAFRIYD MDKDGYISNG ELFQVLKMMV GNNLKDTQLQ QIVDKTIINA DKDGDGRISF EEFCAVVGGL DIHKKMVVDV //